Clinical Trial Update: Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ofatumumab with or without bendamustine for mantle cell lymphoma ineligible for autologous stem cell transplant; results posted after c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Bendamustine (Treanda) (bendamustine)
• Ofatumumab (Arzerra) (Ofatumumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2025-02-28